Background
The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown.Methods
In this double-blind trial, we randomly assigned patients with type 2 diabetes and high cardiovascular risk t...
